PharmaDrug: Cepharanthine Identified For Potential To Bind To Monkeypox Proteins In Independent Screening

PharmaDrug (CSE: PHRX) is reporting this morning that cepharanthine, of which their subsidiary has developed a patented version with enhanced oral bioavailability, has been highlighted as having the potential to bind to monkeypox proteins following an independent screening of drugs to treat the disease.

Read more